ETRACS Monthly Pay 1.5X Leveraged Closed-End Fund Index ETN (NY:CEFD)
Price and Volume
Detailed Quote| Volume | 1,122 |
| Open | 19.11 |
| Bid (Size) | 19.01 (100) |
| Ask (Size) | 28.84 (100) |
| Prev. Close | 19.25 |
| Today's Range | 19.11 - 19.20 |
| 52wk Range | 15.47 - 20.50 |
| Shares Outstanding | 4,000 |
| Dividend Yield | 13.50% |
Top News
More News
Performance
More News
Read More
Frequently Asked Questions
Is ETRACS Monthly Pay 1.5X Leveraged Closed-End Fund Index ETN publicly traded?
Yes, ETRACS Monthly Pay 1.5X Leveraged Closed-End Fund Index ETN is publicly traded.
What exchange does ETRACS Monthly Pay 1.5X Leveraged Closed-End Fund Index ETN trade on?
ETRACS Monthly Pay 1.5X Leveraged Closed-End Fund Index ETN trades on the New York Stock Exchange
What is the ticker symbol for ETRACS Monthly Pay 1.5X Leveraged Closed-End Fund Index ETN?
The ticker symbol for ETRACS Monthly Pay 1.5X Leveraged Closed-End Fund Index ETN is CEFD on the New York Stock Exchange
What is the current price of ETRACS Monthly Pay 1.5X Leveraged Closed-End Fund Index ETN?
The current price of ETRACS Monthly Pay 1.5X Leveraged Closed-End Fund Index ETN is 19.20
When was ETRACS Monthly Pay 1.5X Leveraged Closed-End Fund Index ETN last traded?
The last trade of ETRACS Monthly Pay 1.5X Leveraged Closed-End Fund Index ETN was at 07/08/26 08:00 PM ET
What is the market capitalization of ETRACS Monthly Pay 1.5X Leveraged Closed-End Fund Index ETN?
The market capitalization of ETRACS Monthly Pay 1.5X Leveraged Closed-End Fund Index ETN is 76.79K
How many shares of ETRACS Monthly Pay 1.5X Leveraged Closed-End Fund Index ETN are outstanding?
ETRACS Monthly Pay 1.5X Leveraged Closed-End Fund Index ETN has 77K shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.